You are here

Balversa

Padcev, Keytruda, and Balversa leave little room for Opdivo in urothelial carcinoma

Clinical Trials Arena

Thu, 03/21/24 - 06:41 pm

urothelial cancer

Bristol Myers Squibb

Johnson & Johnson wins full FDA approval for bladder cancer therapy Balversa

Seeking Alpha

Sun, 01/21/24 - 05:11 pm

urothelial cancer

ASCO: Johnson & Johnson's Balversa tops chemotherapy in bladder cancer trial

Fierce Pharma

Mon, 06/5/23 - 10:02 pm

ASCO: Is another pan-tumor drug on the horizon? Johnson & Johnson thinks Balversa could be it

Fierce Pharma

Fri, 05/27/22 - 10:19 am

5 Biggest New Drugs Approved in 2019 So Far

Motley Fool

Tue, 08/13/19 - 11:43 am

multiple sclerosis

metastatic bladder cancer

J&J's Balversa gets accelerated approval for bladder cancer

BioCentury

Fri, 04/12/19 - 11:40 pm